If intolerable side effects or inadequate improvement May offer a different medication in the same class or a medication from a different class CP For pts on antimuscarinics switching to a 3 agonist may be more tolerable due to apparently lower rates of c

If intolerable side effects or inadequate improvement: May offer a different medication in the same class or a medication from a different class. [CP] For pts on antimuscarinics, switching to a β3 agonist may be more tolerable, due to apparently lower rates of common side effects, while maintaining efficacy.